HLA-B27 misfolding and ankylosing spondylitis

Molecular Immunology

Volumn 57, Issue 1, 2014, Pages 44-51

  Colbert, Robert A ^a   Tran, Tri M ^a   Layh Schmitt, Gerlinde ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Ankylosing spondylitis; Autophagy; Endoplasmic reticulum stress; MHC class I; Protein misfolding; Spondyloarthritis; Unfolded protein response

Indexed keywords

BETA INTERFERON; HLA B27 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 23; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL EXPERIMENT; ANKYLOSING SPONDYLITIS; AUTOPHAGY; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENDOPLASMIC RETICULUM STRESS; MAJOR HISTOCOMPATIBILITY COMPLEX; MUTAGENESIS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; RAT; REVIEW; TRANSGENIC RAT;

ANKYLOSING SPONDYLITIS; AUTOPHAGY; ENDOPLASMIC RETICULUM STRESS; MHC CLASS I; PROTEIN MISFOLDING; SPONDYLOARTHRITIS; UNFOLDED PROTEIN RESPONSE;

ANIMALS; ENDOPLASMIC RETICULUM STRESS; HEAT-SHOCK PROTEINS; HLA-B27 ANTIGEN; HUMANS; INTERFERON-BETA; INTERLEUKIN-1ALPHA; INTERLEUKIN-23; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN FOLDING; RATS; SPONDYLITIS, ANKYLOSING; UBIQUITIN-PROTEIN LIGASES; UNFOLDED PROTEIN RESPONSE;

RATTUS;

EID: 84884414051     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.07.013     Document Type: Review

References (78)

1. Allen R.L., O'Callaghan C.A., McMichael A.J., Bowness P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. Journal of Immunology 1999, 162:5045-5048.
2. Amano T., Yamasaki S., Yagishita N., Tsuchimochi K., Shin H., Kawahara K., Aratani S., Fujita H., Zhang L., Ikeda R., et al. Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes & Development 2003, 17:2436-2449.
3. Antoniou A.N., Ford S., Taurog J.D., Butcher G.W., Powis S.J. Formation of HLA-B27 homodimers and their relationship to assembly kinetics. Journal of Biological Chemistry 2004, 279:8895-8902.
4. Benjamin R.J., Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunology Today 1990, 11:137-142.
5. Bird L.A., Peh C.A., Kollnberger S., Elliott T., McMichael A.J., Bowness P. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. European Journal of Immunology 2003, 33:748-759.
6. Bowness P., Ridley A., Shaw J., Chan A.T., Wong-Baeza I., Fleming M., Cummings F., McMichael A., Kollnberger S. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. Journal of Immunology 2011, 186:2672-2680.
7. Burr M.L., Cano F., Svobodova S., Boyle L.H., Boname J.M., Lehner P.J. HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2034-2039.
8. Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., Kwiatkowski D.P., McCarthy M.I., Ouwehand W.H., Samani N.J., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics 2007, 39:1329-1337.
9. Campbell E.C., Fettke F., Bhat S., Morley K.D., Powis S.J. Expression of MHC class I dimers and ERAP1 in an ankylosing spondylitis patient cohort. Immunology 2011, 133:379-385.
10. Cauli A., Dessole G., Fiorillo M.T., Vacca A., Mameli A., Bitti P., Passiu G., Sorrentino R., Mathieu A. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology (Oxford) 2002, 41:1375-1379.
11. Cauli A., Dessole G., Vacca A., Porru G., Cappai L., Piga M., Bitti P.P., Fiorillo M.T., Sorrentino R., Carcassi C., et al. Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time. Scandinavian Journal of Rheumatology 2012, 41:214-218.
12. Ciccia F., Accardo-Palumbo A., Alessandro R., Rizzo A., Principe S., Peralta S., Raiata F., Giardina A., De Leo G., Triolo G. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis & Rheumatism 2012, 64:1869-1878.
13. Ciccia F., Accardo-Palumbo A., Rizzo A., Guggino G., Raimondo S., Giardina A., Can-nizzaro A., Colbert R.A., Alessandro R., Triolo G. Evidence that autophagy,but not the unfolded protein response, regulates the expression of IL-23 in thegut of patients with ankylosing spondylitis and subclinical gut inflammation. Annals of the Rheumatic Diseases 2013, Published Online First: [5 Jun, 2013]. 10.1136/annrheumdis-2012-202925.
14. Ciccia F., Bombardieri M., Principato A., Giardina A., Tripodo C., Porcasi R., Peralta S., Franco V., Giardina E., Craxi A., et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis & Rheumatism 2009, 60:955-965.
15. Colbert R.A. HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum?. Molecular Medicine Today 2000, 6:224-230.
16. Colbert R.A., DeLay M.L., Klenk E.I., Layh-Schmitt G. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunological Reviews 2010, 233:181-202.
17. Cortes A., Hadler J., Pointon J.P., Robinson P.C., Karaderi T., Leo P., Cremin K., Pryce K., Harris J., Lee S., et al. Identification of multiple risk variantsfor ankylosing spondylitis through high-density genotyping of immune-relatedloci. Nature Genetics 2013, 45:730-738. International Genetics of Ankylosing Spondylitis Consortium (IGAS).
18. Dangoria N.S., DeLay M.L., Kingsbury D.J., Mear J.P., Uchanska-Ziegler B., Ziegler A., Colbert R.A. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. Journal of Biological Chemistry 2002, 277:23459-23468.
19. DeLay M.L., Turner M.J., Klenk E.I., Smith J.A., Sowders D.P., Colbert R.A. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis & Rheumatism 2009, 60:2633-2643.
20. Dickhout J.G., Lhotak S., Hilditch B.A., Basseri S., Colgan S.M., Lynn E.G., Carlisle R.E., Zhou J., Sood S.K., Ingram A.J., et al. Induction of the unfolded protein response after monocyte to macrophage differentiation augments cell survival in early atherosclerotic lesions. FASEB Journal 2011, 25:576-589.
21. Dong W., Zhang Y., Yan M., Liu H., Chen Z., Zhu P. Upregulation of 78-kDa glucose-regulated protein in macrophages in peripheral joints of active ankylosing spondylitis. Scandinavian Journal of Rheumatology 2008, 37:1-8.
22. Dougados M., Baeten D. Spondyloarthritis. Lancet 2011, 377:2127-2137.
23. Edwards J.C.W., Bowness P., Archer J.R. Jekyll and Hyde: the transformation of HLA-B27. Immunology Today 2000, 21:256-260.
24. Ellgaard L., Helenius A. Quality control in the endoplasmic reticulum. Nature Reviews Molecular Cell Biology 2003, 4:181-191.
25. Evans D.M., Spencer C.C., Pointon J.J., Su Z., Harvey D., Kochan G., Oppermann U., Dilthey A., Pirinen M., Stone M.A., et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genetics 2011, 43:761-767.
26. Feng Y., Ding J., Fan C.M., Zhu P. Interferon-gamma contributes to HLA-B27-associated unfolded protein response in spondyloarthropathies. Journal of Rheumatology 2012, 39:574-582.
27. Fussell H., Nesbeth D., Lenart I., Campbell E.C., Lynch S., Santos S., Gould K., Powis S.J., Antoniou A.N. Novel detection of in vivo HLA-B27 conformations correlates with ankylosing spondylitis association. Arthritis & Rheumatism 2008, 58:3419-3424.
28. Goodall J.C., Wu C., Zhang Y., McNeill L., Ellis L., Saudek V., Gaston J.S. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:17698-17703.
29. Gregersen N., Bross P. Protein misfolding and cellular stress: an overview. Methods in Molecular Biology 2010, 648:3-23.
30. Gu J., Rihl M., Marker-Hermann E., Baeten D., Kuipers J.G., Song Y.W., Maksymowych W.P., Burgos-Vargas R., Veys E.M., De Keyser F., et al. Clues to the pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. Journal of Rheumatology 2002, 29:2159-2164.
31. 2-m: an animal model of HLA-B27-associated human disorders. Cell 1990, 63:1099-1112.
32. Helmick C.G., Felson D.T., Lawrence R.C., Gabriel S., Hirsch R., Kwoh C.K., Liang M.H., Kremers H.M., Mayes M.D., Merkel P.A., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis & Rheumatism 2008, 58:15-25.
33. Hetz C., Thielen P., Matus S., Nassif M., Court F., Kiffin R., Martinez G., Cuervo A.M., Brown R.H., Glimcher L.H. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes & Development 2009, 23:2294-2306.
34. Hou F.F., Miyata T., Boyce J., Yuan Q., Chertow G.M., Kay J., Schmidt A.M., Owen W.F. beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney International 2001, 59:990-1002.
35. Hughes E.A., Hammond C., Cresswell P. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:1896-1901.
36. Iwakoshi N.N., Pypaert M., Glimcher L.H. The transcription factor XBP-1 is essential for the development and survival of dendritic cells. Journal of Experimental Medicine 2007, 204:2267-2275.
37. Jaakkola E., Herzberg I., Laiho K., Barnardo M.C., Pointon J.J., Kauppi M., Kaarela K., Tuomilehto-Wolf E., Tuomilehto J., Wordsworth B.P., et al. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Annals of the Rheumatic Diseases 2006, 65:775-780.
38. Jacques P., Van Praet L., Carron P., Van den Bosch F., Elewaut D. Pathophysiology and role of the gastrointestinal system in spondyloarthritides. Rheumatic Disease Clinics of North America 2012, 38:569-582.
39. Jardetzky T.S., Lane W.S., Robinson R.A., Madden D.R., Wiley D.C. Identification of self peptides bound to purified HLA-B27. Nature 1991, 353:326-329.
40. Kenna T.J., Davidson S.I., Duan R., Bradbury L.A., McFarlane J., Smith M., Weedon H., Street S., Thomas R., Thomas G.P., et al. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma/delta T cells in patients with active ankylosing spondylitis. Arthritis & Rheumatism 2012, 64:1420-1429.
41. Kollnberger S., Bird L.A., Sunm M.-Y., Retiere C., Braud V.M., McMichael A., Bowness P. Cell surface expression and immune receptor recogntion of HLA-B27 homodimers. Arthritis & Rheumatism 2002, 46:2972-2982.
42. Kroemer G., Marino G., Levine B. Autophagy and the integrated stress response. Molecular Cell 2010, 40:280-293.
43. Kundu M., Thompson C.B. Autophagy: basic principles and relevance to disease. Annual Review of Pathology 2008, 3:427-455.
44. Layh-Schmitt G., Colbert R.A. The interleukin-23/interleukin-17 axis in spondyloarthritis. Current Opinion in Rheumatology 2008, 20:392-397.
45. Layh-Schmitt G., Yang E.Y., Kwon G., Colbert R.A. HLA-B27 alters the response to TNFalpha and promotes osteoclastogenesis in bone marrow monocytes from HLA-B27 transgenic rats. Arthritis & Rheumatism 2013, 65:2123-2131.
46. Lenart I., Guiliano D.B., Burn G., Campbell E.C., Morley K.D., Fussell H., Powis S.J., Antoniou A.N. The MHC class I heavy chain structurally conserved cysteines 101 and 164 participate in HLA-B27 dimer formation. Antioxidants & Redox Signaling 2012, 16:33-43.
47. Madden D.R., Garboczi D.N., Wiley D.C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993, 75:693-708.
48. Martinon F., Chen X., Lee A.H., Glimcher L.H. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nature Immunology 2010, 11:411-418.
49. Mear J.P., Schreiber K.L., Munz C., Zhu X., Stevanovic S., Rammensee H.-G., Rowland-Jones S.L., Colbert R.A. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. Journal of Immunology 1999, 163:6665-6670.
50. Miyata T., Hori O., Zhang J., Yan S.D., Ferran L., Iida Y., Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway, implications for the pathogenesis of dialysis-related amyloidosis. Journal of Clinical Investigation 1996, 98:1088-1094.
51. Molinari M., Galli C., Piccaluga V., Pieren M., Paganetti P. Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER. Journal of Cell Biology 2002, 158:247-257.
52. Molinari M., Galli C., Vanoni O., Arnold S.M., Kaufman R.J. Persistent glycoprotein misfolding activates the glucosidase II/UGT1-driven calnexin cycle to delay aggregation and loss of folding competence. Molecular Cell 2005, 20:503-512.
53. Noessner E., Parham P. Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules. Journal of Experimental Medicine 1995, 181:327-337.
54. Ogata M., Hino S., Saito A., Morikawa K., Kondo S., Kanemoto S., Murakami T., Taniguchi M., Tanii I., Yoshinaga K., et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Molecular and Cellular Biology 2006, 26:9220-9231.
55. Peral de Castro C., Jones S.A., Ni Cheallaigh C., Hearnden C.A., Williams L., Winter J., Lavelle E.C., Mills K.H., Harris J. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. Journal of Immunology 2012, 189:4144-4153.
56. Reveille J.D. Genetics of spondyloarthritis - beyond the MHC. Nature Reviews Rheumatology 2012, 8:296-304.
57. Reveille J.D., Sims A.M., Danoy P., Evans D.M., Leo P., Pointon J.J., Jin R., Zhou X., Bradbury L.A., Appleton L.H., et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nature Genetics 2010, 42:123-127.
58. Rouschop K.M., van den Beucken T., Dubois L., Niessen H., Bussink J., Savelkouls K., Keulers T., Mujcic H., Landuyt W., Voncken J.W., et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. Journal of Clinical Investigation 2010, 120:127-141.
59. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. Journal of Clinical Investigation 2001, 108:949-955.
60. Shen H., Goodall J.C., Hill Gaston J.S. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis & Rheumatism 2009, 60:1647-1656.
61. Sherlock J.P., Joyce-Shaikh B., Turner S.P., Chao C.C., Sathe M., Grein J., Gorman D.M., Bowman E.P., McClanahan T.K., Yearley J.H., et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nature Medicine 2012, 18:1069-1076.
62. Smith J.A., Barnes M.D., Hong D., DeLay M.L., Inman R.D., Colbert R.A. Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-gamma dysregulation. Arthritis & Rheumatism 2008, 58:1640-1649.
63. Smith J.A., Turner M.J., DeLay M.L., Klenk E.I., Sowders D.P., Colbert R.A. Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-beta induction via X-box binding protein 1. European Journal of Immunology 2008, 38:1194-1203.
64. Song I.H., Maksymowych W.P. Therapeutic controversies: tumor necrosis factor alpha inhibitors in ankylosing spondylitis. Rheumatic Disease Clinics of North America 2012, 38:613-633.
65. Stam N.J., Spits H., Ploegh H.L. Monoclonal antibodies raised against denatured HLA-B locus H-chains permit biochemical characterization of certain HLA-C locus products. Journal of Immunology 1986, 137:2299-2306.
66. Takayanagi H., Kim S., Matsuo K., Suzuki H., Suzuki T., Sato K., Yokochi T., Oda H., Nakamura K., Ida N., et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 2002, 416:744-749.
67. Taurog J.D., Maika S.D., Satumtira N., Dorris M.L., McLean I.L., Yanagisawa H., Sayad A., Stagg A.J., Fox G.M., O'Brien A.L., et al. Inflammatory disease in HLA-B27 transgenic rats. Immunological Reviews 1999, 169:209-223.
68. Taurog J.D., Maika S.D., Simmons W.A., Breban M., Hammer R.E. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. Journal of Immunology 1993, 150:4168-4178.
69. Tran T.M., Dorris M.L., Satumtira N., Richardson J.A., Hammer R.E., Shang J., Taurog J.D. Additional human beta(2)-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis & Rheumatism 2006, 54:1317-1327.
70. Tran T.M., Satumtira N., Dorris M.L., May E., Wang A., Furuta E., Taurog J.D. HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP. Journal of Immunology 2004, 172:5110-5119.
71. Turner M.J., Delay M.L., Bai S., Klenk E., Colbert R.A. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease. Arthritis & Rheumatism 2007, 56:215-223.
72. Turner M.J., Sowders D.P., DeLay M.L., Mohapatra R., Bai S., Smith J.A., Brandewie J.R., Taurog J.D., Colbert R.A. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. Journal of Immunology 2005, 175:2438-2448.
73. Vidal R.L., Hetz C. Unspliced XBP1 controls autophagy through FoxO1. Cell Research 2013, 23:463-464.
74. Wendling D., Cedoz J.P., Racadot E., Dumoulin G. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine 2007, 74:304-305.
75. Yarilina A., Park-Min K.H., Antoniv T., Hu X., Ivashkiv L.B. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nature Immunology 2008, 9:378-387.
76. Zeng L., Lindstrom M.J., Smith J.A. Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis & Rheumatism 2011, 63:3807-3817.
77. Zeng L., Liu Y.P., Sha H., Chen H., Qi L., Smith J.A. XBP-1 couples endoplasmic reticulum stress to augmented IFN-beta induction via a cis-acting enhancer in macrophages. Journal of Immunology 2010, 185:2324-2330.
78. Zhao Y., Li X., Cai M.Y., Ma K., Yang J., Zhou J., Fu W., Wei F.Z., Wang L., Xie D., et al. XBP-1u suppresses autophagy by promoting the degradation of FoxO1 in cancer cells. Cell Research 2013, 23:491-507.